Bouligny, Ian M. https://orcid.org/0000-0002-4274-4249
Montalban-Bravo, Guillermo https://orcid.org/0000-0002-4533-5176
Sasaki, Koji https://orcid.org/0000-0002-9140-0610
Daver, Naval https://orcid.org/0000-0001-7103-373X
Jabbour, Elias https://orcid.org/0000-0003-4465-6119
Alvarado, Yesid https://orcid.org/0000-0002-1652-7937
DiNardo, Courtney D. https://orcid.org/0000-0001-9003-0390
Ravandi, Farhad https://orcid.org/0000-0002-7621-377X
Borthakur, Gautam https://orcid.org/0000-0001-7679-6453
Pemmaraju, Naveen https://orcid.org/0000-0002-1670-6513
Kadia, Tapan https://orcid.org/0000-0002-9892-9832
Masarova, Lucia
Takahashi, Koichi https://orcid.org/0000-0002-8027-9659
Andreeff, Michael https://orcid.org/0000-0002-1144-1958
Bazinet, Alexandre
Yang, Hui
Kanagal, Rashmi https://orcid.org/0000-0001-7829-5249
Pierce, Sherry
Meyer, Meghan
Huang, Xuelin https://orcid.org/0000-0003-1192-9336
Garcia-Manero, Guillermo https://orcid.org/0000-0002-3631-2482
Funding for this research was provided by:
The University of Texas MD Anderson Cancer Center Support Grant CA01667 The University of Texas MD Anderson Cancer Center MDS/AML Moon Shot Bristol Myers Squibb Alliance
Article History
Received: 14 August 2024
Revised: 24 October 2024
Accepted: 29 October 2024
First Online: 17 November 2024
Competing interests
: The authors declare no competing interests.
: The MD Anderson Institutional Review Board approved this study. All patients provided written informed consent according to the Declaration of Helsinki.